4.7 Article

Genetic Predisposition to Weight Loss and Regain With Lifestyle Intervention: Analyses From the Diabetes Prevention Program and the Look AHEAD Randomized Controlled Trials

期刊

DIABETES
卷 64, 期 12, 页码 4312-4321

出版社

AMER DIABETES ASSOC
DOI: 10.2337/db15-0441

关键词

-

资金

  1. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK072041-02, DK056992-14S1]
  2. Department of Veterans Affairs
  3. Doris Duke Charitable Foundation Clinical Scientist Development Award
  4. Swedish Heart-Lung Foundation
  5. Novo Nordisk Foundation
  6. Swedish Research Council
  7. EXODIAB
  8. Swedish Diabetes Association
  9. NIDDK of the National Institutes of Health (NIH)
  10. NIDDK
  11. Indian Health Service
  12. NIH Office of Research on Minority Health
  13. Eunice Kennedy Shriver National Institute of Child Health and Human Development
  14. National Institute on Aging
  15. Centers for Disease Control and Prevention
  16. NIH Office of Research on Women's Health
  17. American Diabetes Association
  18. Intramural Research Program of the NIDDK
  19. Novo Nordisk Fonden [NNF13OC0005781, NNF12OC1016167, NNF14OC0011039, NNF11OC1014855] Funding Source: researchfish

向作者/读者索取更多资源

Clinically relevant weight loss is achievable through lifestyle modification, but unintentional weight regain is common. We investigated whether recently discovered genetic variants affect weight loss and/or weight regain during behavioral intervention. Participants at high-risk of type 2 diabetes (Diabetes Prevention Program [DPP]; N = 917/907 intervention/comparison) or with type 2 diabetes (Look AHEAD [Action for Health in Diabetes]; N = 2,014/1,892 intervention/comparison) were from two parallel arm (lifestyle vs. comparison) randomized controlled trials. The associations of 91 established obesity-predisposing loci with weight loss across 4 years and with weight regain across years 2-4 after a minimum of 3% weight loss were tested. Each copy of the minor G allele of MTIF3 rs1885988 was consistently associated with greater weight loss following lifestyle intervention over 4 years across the DPP and Look AHEAD. No such effect was observed across comparison arms, leading to a nominally significant single nucleotide polymorphism x treatment interaction (P = 4.3 x 10(-3)). However, this effect was not significant at a study-wise significance level (Bonferroni threshold P < 5.8 x 10(-4)). Most obesity-predisposing gene variants were not associated with weight loss or regain within the DPP and Look AHEAD trials, directly or via interactions with lifestyle.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据